Xeris Biopharma: Q3 Earnings Snapshot
In this article:
CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported a loss of $12.2 million in its third quarter.
The Chicago-based company said it had a loss of 9 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.
The company posted revenue of $48.3 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $40.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS
